David G. Orloff
David G. Orloff publishes mostly in Surgery, Immunology and Molecular Biology, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #966,036 of 7,710,434 ranked researchers
- Rank in United States
- #316,594 of 1,627,098
- Works
- 34
- Citations
- 1.9k
- Citations per work
- 56.8
What does David G. Orloff research?
David G. Orloff's work is mostly in Medicine (36%), Immunology and Microbiology (14%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1235.9%
- Medicine1235.9%
- Life Sciences926.1%
- Everything else926.0%
- Social Sciences412.0%
- 1Surgery21% of their works
- 2Immunology14% of their works
- 3Molecular Biology12% of their works
- 4Economics and Econometrics12% of their works
- 5Endocrinology, Diabetes and Metabolism8% of their works
- 6Cardiology and Cardiovascular Medicine8% of their works
Research topics
Which keywords describe David G. Orloff's research?
The keywords of their largest research topics: Cholesterol-lowering, Statins, Cardiovascular Disease, Metabolic Syndrome, Cost-effectiveness Analysis, Diabetes, Insulin Resistance and Quality of Life.
- Omega-3 Fatty Acids
- Inflammation
- TGF-ß
- NK Cell Recognition
- Foxp3
- Quality of Life
- Diabetes
- Metabolic Syndrome
- Statins
- Cholesterol-lowering
- Cardiovascular Disease
- Cost-effectiveness Analysis
- Insulin Resistance
- Drug Development Costs
- Generic Drugs
- Natural Killer Cells
- ANGPTL3
- Lipoprotein Lipase
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Cholesterol-lowering171 topic
- Statins171 topic
- Cardiovascular Disease102 topics
- Metabolic Syndrome102 topics
- Cost-effectiveness Analysis61 topic
- Diabetes61 topic
- Insulin Resistance61 topic
- Quality of Life61 topic
- Drug Development Costs51 topic
- Foxp351 topic
- Generic Drugs51 topic
- NK Cell Recognition51 topic
- Natural Killer Cells51 topic
- TGF-ß51 topic
- ANGPTL341 topic
- Inflammation41 topic
- Lipoprotein Lipase41 topic
- Omega-3 Fatty Acids41 topic
Where does David G. Orloff work?
David G. Orloff's main affiliation in the publication record is Medpace (United States), United States.
How many publications and citations does David G. Orloff have?
OpenAlex counts 34 works and 1,931 citations for David G. Orloff, an h-index of 18, ranking #966,036 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David G. Orloff. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.